Physician variation in management of low-risk prostate cancer: a population-based cohort study
about
An Update on Triptorelin: Current Thinking on Androgen Deprivation Therapy for Prostate CancerCancer screening in the United States, 2015: a review of current American cancer society guidelines and current issues in cancer screeningThe high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the Prostate-specific Antigen-era.Regional differences in recommended cancer treatment for the elderly.Re: Long-term Follow-up of a Large Active Surveillance Cohort of Patients with Prostate CancerIntermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer.Patients' Survival Expectations With and Without Their Chosen Treatment for Prostate Cancer.Cardiac Monitoring During Adjuvant Trastuzumab-Based Chemotherapy Among Older Patients With Breast Cancer.Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer.Assessment of duration until initial treatment and its determining factors among newly diagnosed oral cancer patients: A population-based retrospective cohort study.Expectant management of veterans with early-stage prostate cancer.Second opinions from urologists for prostate cancer: Who gets them, why, and their link to treatment.Qualitative study on decision-making by prostate cancer physicians during active surveillance.Impact of urologists' ownership of radiation equipment in the treatment of prostate cancer.Does true Gleason pattern 3 merit its cancer descriptor?Barriers to evidence-based physician decision-making at the point of care: a narrative literature review.Advances in Prostate Cancer Magnetic Resonance Imaging and Positron Emission Tomography-Computed Tomography for Staging and Radiotherapy Treatment Planning.Pathologic correlation of transperineal in-bore 3-Tesla magnetic resonance imaging-guided prostate biopsy samples with radical prostatectomy specimen.The uptake of active surveillance for the management of prostate cancer: A population-based analysis.PITX3 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients after radical prostatectomy.Active surveillance in Canadian men with low-grade prostate cancer.How Men with Prostate Cancer Choose Specialists: A Qualitative Study.Oncological and functional outcomes 1 year after radical prostatectomy for very-low-risk prostate cancer: results from the prospective LAPPRO trial.Treatment Preferences for Active Surveillance versus Active Treatment among Men with Low-Risk Prostate Cancer.Physician Recommendations Trump Patient Preferences in Prostate Cancer Treatment Decisions.Active surveillance in prostate cancer: new efforts, new voices, new hope.Variation in the use of active surveillance for low-risk prostate cancer.Utilization and predictors of expectant management among elderly men with low-and intermediate-risk localized prostate cancer in U.S. urological practice.Role of Leadership in Narrowing the Gap between Science and Practice: Improving Treatment Outcomes at the Systems Level.Can exercise delay transition to active therapy in men with low-grade prostate cancer? A multicentre randomised controlled trial.Practice- vs Physician-Level Variation in Use of Active Surveillance for Men With Low-Risk Prostate Cancer: Implications for Collaborative Quality Improvement.Association between physician medical school ranking and patient outcomes and costs of care: observational study
P2860
Q26744431-BD059221-8BE8-41C0-9498-E2FA38E8FE44Q27001043-AA24A1DD-2152-4114-A34E-8E95837EBA0FQ34042937-7378DD69-49BA-4DFE-8AEC-DD857E4DDCDCQ36078035-7CD0DDF6-7085-4413-9BD3-13F246119D6DQ36787658-48F6E95C-EC4E-4EDB-836C-5F850ED39014Q36892392-C2AB30B7-9A09-41A5-90D2-F029284E8F6FQ36905270-F8F3F913-D67C-44D5-BE32-574AFB44E8E2Q37163787-CCD51B69-6987-45F3-B183-DB018CE87F8FQ37246641-69D541F8-8979-4B6B-8CD5-49E210E62ED4Q37608390-726EE23E-97C6-4230-9F44-69F7CAD52CF4Q38626027-5AAF7101-55BD-44F1-AF44-29B474348078Q38750153-5FB65E7B-D43E-4C3A-BC7D-B6836BB7D7D4Q38822928-EEEB9AD6-1981-42A7-970A-7AFE5B07B9C1Q38871505-6FF27438-A6B3-4228-A60C-9E933C6FC31BQ38928930-06A65003-FBB2-40DE-AB58-883A0988F422Q39034197-FF62AD70-76C8-4A86-A90F-A4D3727EA1FDQ39041614-BADE3C55-6C53-4EB2-9536-14A264E8CA68Q39178750-D8824144-B182-4E00-AE65-152DE0DCA658Q39229118-268729F5-6FCB-47F1-9EED-13AA664037A0Q39318240-FEEA678D-A149-4856-BF6E-7D7497AD48A3Q39958888-656E44E9-1D60-435B-8D7B-AE078C9D7008Q40256827-0E1D581B-475D-43C6-BFBB-75F71B3D527EQ40916081-BCC19D78-4E23-409C-975F-604FEFB970AAQ42265374-6C2AB0E8-E281-48D5-A649-4D26DE7E8F81Q45942807-84815C31-80AF-49BB-90D7-E7A1D57B9E5BQ47573871-F4EB4AAE-EE16-40A4-A5D8-2185406CEAC3Q47809867-0923653F-119B-45DB-A05F-AF309AF55395Q50503378-9B57388C-946D-4A73-8875-2E9429D4E75CQ50584010-67EAC569-EE5F-4738-B8D9-D088F1CBC79AQ52573392-5B776571-358D-489B-9D02-8DD6966C4507Q55238647-65B586D8-389D-4138-8916-13E4BC359D8DQ58696374-7CED5B1F-7B56-4C66-901F-4C011083AEF1
P2860
Physician variation in management of low-risk prostate cancer: a population-based cohort study
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Physician variation in managem ...... population-based cohort study
@ast
Physician variation in managem ...... population-based cohort study
@en
type
label
Physician variation in managem ...... population-based cohort study
@ast
Physician variation in managem ...... population-based cohort study
@en
prefLabel
Physician variation in managem ...... population-based cohort study
@ast
Physician variation in managem ...... population-based cohort study
@en
P2093
P2860
P1476
Physician variation in managem ...... population-based cohort study
@en
P2093
Benjamin D Smith
Deborah A Kuban
George H Perkins
Grace L Smith
Jay B Shah
Jiangong Niu
Jing Jiang
John W Davis
Karen E Hoffman
P2860
P304
P356
10.1001/JAMAINTERNMED.2014.3021
P577
2014-09-01T00:00:00Z